Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study

dc.contributor.authorCarlos O. Mendivil
dc.contributor.authorFreddy JK Toloza
dc.contributor.authorMaria Laura Ricardo-Silgado
dc.contributor.authorMartha Catalina Morales-Álvarez
dc.contributor.authorJosé O. Mantilla-Rivas
dc.contributor.authorJairo A Pinzón-Cortés
dc.contributor.authorHernan Nicolás Lemus
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:07:50Z
dc.date.available2026-03-22T15:07:50Z
dc.date.issued2017
dc.descriptionCitaciones: 6
dc.description.abstractBackground: Autoimmunity against insulin-producing beta cells from pancreatic islets is a common phenomenon in type 1 diabetes and latent autoimmune diabetes in adults. Some reports have also related beta-cell autoimmunity to insulin resistance (IR) in type 2 diabetes. However, the extent to which autoimmunity against components of beta cells is present and relates to IR and insulin secretion in nondiabetic adults is uncertain. Aim: To explore the association between antibodies against glutamic acid decarboxylase (GADA), a major antigen from beta cells, and indices of whole-body IR and beta-cell capacity/insulin secretion in adults who do not have diabetes. Methods: We studied 81 adults of both sexes aged 30–70, without known diabetes or any autoimmune disease. Participants underwent an oral glucose tolerance test (OGTT) with determination of plasma glucose and insulin at 0, 30, 60, 90, and 120 minutes. From these results we calculated indices of insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR] and incremental area under the insulin curve [iAUCins]) and insulin secretion (corrected insulin response at 30 minutes and HOMA beta-cell%). GADAs were measured in fasting plasma using immunoenzymatic methods. Results: We found an overall prevalence of GADA positivity of 21.3%, without differences by sex and no correlation with age. GADA titers did not change monotonically across quartiles of any of the IR or insulin secretion indices studies. GADA did not correlate linearly with fasting IR expressed as HOMA-IR (Spearman’s r =−0.18, p =0.10) or postabsorptive IR expressed as iAUCins ( r =−0.15, p =0.18), but did show a trend toward a negative correlation with insulin secretory capacity expressed by the HOMA-beta cell% index ( r =−0.20, p =0.07). Hemoglobin A1c, body mass index, and waist circumference were not associated with GADA titers. Conclusion: GADA positivity is frequent and likely related to impaired beta-cell function among adults without known diabetes. Keywords: insulin resistance, autoimmunity, glutamate decarboxylase, latent autoimmune diabetes in adults, beta cell
dc.identifier.doi10.2147/dmso.s137216
dc.identifier.urihttps://doi.org/10.2147/dmso.s137216
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/50558
dc.language.isoen
dc.publisherDove Medical Press
dc.relation.ispartofDiabetes Metabolic Syndrome and Obesity
dc.sourceUniversidad de Los Andes
dc.subjectInsulin resistance
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectInsulin
dc.subjectDiabetes mellitus
dc.subjectAutoimmunity
dc.subjectType 1 diabetes
dc.subjectGlucose homeostasis
dc.subjectBeta cell
dc.subjectMedicine
dc.titleAntibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
dc.typearticle

Files